These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19404532)

  • 1. Do common prothrombotic mutations influence the risk of cerebral ischaemia in patients with patent foramen ovale? Systematic review and meta-analysis.
    Pezzini A; Grassi M; Zotto ED; Giossi A; Volonghi I; Costa P; Grau A; Magoni M; Padovani A; Lichy C
    Thromb Haemost; 2009 May; 101(5):813-7. PubMed ID: 19404532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G1691A factor V and G20210A FII mutations, acute ischemic stroke of unknown cause, and patent foramen ovale.
    Favaretto E; Sartori M; Conti E; Legnani C; Palareti G
    Thromb Res; 2012 Nov; 130(5):720-4. PubMed ID: 22909823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale.
    Pezzini A; Del Zotto E; Magoni M; Costa A; Archetti S; Grassi M; Akkawi NM; Albertini A; Assanelli D; Vignolo LA; Padovani A
    Stroke; 2003 Jan; 34(1):28-33. PubMed ID: 12511746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prothrombin G20210A mutation, but not factor V Leiden, is a risk factor in patients with persistent foramen ovale and otherwise unexplained cerebral ischemia.
    Lichy C; Reuner KH; Buggle F; Litfin F; Rickmann H; Kunze A; Brandt T; Grau A
    Cerebrovasc Dis; 2003; 16(1):83-7. PubMed ID: 12766367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale.
    Botto N; Spadoni I; Giusti S; Ait-Ali L; Sicari R; Andreassi MG
    Stroke; 2007 Jul; 38(7):2070-3. PubMed ID: 17525392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatic ischemic stroke in full-term neonates : role of acquired and genetic prothrombotic risk factors.
    Günther G; Junker R; Sträter R; Schobess R; Kurnik K; Heller C; Kosch A; Nowak-Göttl U;
    Stroke; 2000 Oct; 31(10):2437-41. PubMed ID: 11022077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Patent foramen ovale: "les liaisons dangereuses" between anatomy and genetics].
    Botto N; Ait-Ali L; Sicari R; Spadoni I; Andreassi MG
    Recenti Prog Med; 2009; 100(7-8):356-60. PubMed ID: 19725476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale.
    Karttunen V; Hiltunen L; Rasi V; Vahtera E; Hillbom M
    Blood Coagul Fibrinolysis; 2003 Apr; 14(3):261-8. PubMed ID: 12695749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V G1691A and prothrombin G20210A in childhood spontaneous venous thrombosis--evidence of an age-dependent thrombotic onset in carriers of factor V G1691A and prothrombin G20210A mutation.
    Schobess R; Junker R; Auberger K; Münchow N; Burdach S; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S105-8. PubMed ID: 10650846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic stroke and patent foramen ovale: risk factors and genetic profile.
    Lantz M; Sjöstrand C; Kostulas K
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):841-5. PubMed ID: 22784820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years.
    Lalouschek W; Schillinger M; Hsieh K; Endler G; Tentschert S; Lang W; Cheng S; Mannhalter C
    Stroke; 2005 Jul; 36(7):1405-9. PubMed ID: 15947254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic thrombosis in Turkish neonates.
    Gurgey A; Tekinalp G; Cinar A; Cakmak F
    J Pediatr Hematol Oncol; 2004 Jul; 26(7):417-20. PubMed ID: 15218414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V Leiden and prothrombin 20210G>A [corrected] mutation and paediatric ischaemic stroke: a case-control study and two meta-analyses.
    Laugesaar R; Kahre T; Kolk A; Uustalu U; Kool P; Talvik T
    Acta Paediatr; 2010 Aug; 99(8):1168-74. PubMed ID: 20337781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale.
    Kim YD; Song D; Nam HS; Lee K; Yoo J; Hong GR; Lee HS; Nam CM; Heo JH
    Thromb Haemost; 2015 Aug; 114(3):614-22. PubMed ID: 25994249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor XIII Val34Leu polymorphism and ischaemic stroke in patients with patent foramen ovale.
    Wypasek E; Stepien E; Pieculewicz M; Podolec P; Undas A
    Thromb Haemost; 2009 Dec; 102(6):1280-2. PubMed ID: 19967163
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of classic risk factors and prothrombotic factor gene mutations in ischemic stroke risk development in young and middle-aged individuals.
    Supanc V; Sonicki Z; Vukasovic I; Solter VV; Zavoreo I; Kes VB
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):e171-6. PubMed ID: 24189452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.
    Kim RJ; Becker RC
    Am Heart J; 2003 Dec; 146(6):948-57. PubMed ID: 14660985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patent foramen ovale and prothrombotic markers in young stroke patients.
    Belvís R; Santamaría A; Martí-Fàbregas J; Leta RG; Cocho D; Borrell M; Fontcuberta J; Martí-Vilalta JL
    Blood Coagul Fibrinolysis; 2007 Sep; 18(6):537-42. PubMed ID: 17762528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic yield of prothrombotic state studies in cryptogenic stroke.
    Belvís R; Santamaría A; Martí-Fàbregas J; Cocho D; Borrell M; Fontcuberta J; Martí-Vilalta JL
    Acta Neurol Scand; 2006 Oct; 114(4):250-3. PubMed ID: 16942544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes and a high prevalence of abnormalities on comprehensive arterial and venous thrombophilia screening in TIA or ischaemic stroke patients with a patent foramen ovale, an inter-atrial septal aneurysm or both.
    Lim ST; Murphy SJX; Smith DR; Williams J; Navarro SG; McCabe J; Moore DP; McHugh J; McCabe DJH
    J Neurol Sci; 2017 Jun; 377():227-233. PubMed ID: 28477701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.